332 related articles for article (PubMed ID: 9749657)
1. Trends and black/white differences in treatment for nonmetastatic prostate cancer.
Klabunde CN; Potosky AL; Harlan LC; Kramer BS
Med Care; 1998 Sep; 36(9):1337-48. PubMed ID: 9749657
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
[TBL] [Abstract][Full Text] [Related]
3. Predictors of aggressive therapy for nonmetastatic prostate carcinoma in Massachusetts from 1998 to 2002.
Rose AJ; Backus BM; Gershman ST; Santos P; Ash AS; Battaglia TA
Med Care; 2007 May; 45(5):440-7. PubMed ID: 17446830
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.
Hoffman RM; Harlan LC; Klabunde CN; Gilliland FD; Stephenson RA; Hunt WC; Potosky AL
J Gen Intern Med; 2003 Oct; 18(10):845-53. PubMed ID: 14521648
[TBL] [Abstract][Full Text] [Related]
5. Physician visits prior to treatment for clinically localized prostate cancer.
Jang TL; Bekelman JE; Liu Y; Bach PB; Basch EM; Elkin EB; Zelefsky MJ; Scardino PT; Begg CB; Schrag D
Arch Intern Med; 2010 Mar; 170(5):440-50. PubMed ID: 20212180
[TBL] [Abstract][Full Text] [Related]
6. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.
Zeliadt SB; Potosky AL; Etzioni R; Ramsey SD; Penson DF
Urology; 2004 Dec; 64(6):1171-6. PubMed ID: 15596192
[TBL] [Abstract][Full Text] [Related]
7. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
[TBL] [Abstract][Full Text] [Related]
8. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
9. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.
Hamilton AS; Fleming ST; Wang D; Goodman M; Wu XC; Owen JB; Lo M; Ho A; Anderson RT; Thompson T
Am J Clin Oncol; 2016 Feb; 39(1):55-63. PubMed ID: 24390274
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic.
Bernstein AN; Talwar R; Handorf E; Syed K; Danella J; Ginzburg S; Belkoff L; Reese AC; Tomaszewski J; Trabulsi E; Singer EA; Jacobs B; Kutikov A; Uzzo R; Raman JD; Guzzo T; Smaldone MC; Correa A
JAMA Oncol; 2021 Oct; 7(10):1467-1473. PubMed ID: 34292311
[TBL] [Abstract][Full Text] [Related]
12. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
13. Understanding variation in primary prostate cancer treatment within the Veterans Health Administration.
Nambudiri VE; Landrum MB; Lamont EB; McNeil BJ; Bozeman SR; Freedland SJ; Keating NL
Urology; 2012 Mar; 79(3):537-45. PubMed ID: 22245306
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ
J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292
[TBL] [Abstract][Full Text] [Related]
15. Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States).
Morris CR; Snipes KP; Schlag R; Wright WE
Cancer Causes Control; 1999 Dec; 10(6):503-11. PubMed ID: 10616820
[TBL] [Abstract][Full Text] [Related]
16. Hospital racial composition and the treatment of localized prostate cancer.
Pollack CE; Bekelman JE; Liao KJ; Armstrong K
Cancer; 2011 Dec; 117(24):5569-78. PubMed ID: 21692067
[TBL] [Abstract][Full Text] [Related]
17. Variations in use of imaging in a national sample of men with early-stage prostate cancer.
Saigal CS; Pashos CL; Henning JM; Litwin MS
Urology; 2002 Mar; 59(3):400-4. PubMed ID: 11880080
[TBL] [Abstract][Full Text] [Related]
18. Patterns of prostate cancer treatment by clinical stage and age.
Meltzer D; Egleston B; Abdalla I
Am J Public Health; 2001 Jan; 91(1):126-8. PubMed ID: 11189804
[TBL] [Abstract][Full Text] [Related]
19. Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States.
Mahase SS; D'Angelo D; Kang J; Hu JC; Barbieri CE; Nagar H
JAMA Netw Open; 2020 Feb; 3(2):e1920471. PubMed ID: 32022878
[TBL] [Abstract][Full Text] [Related]
20. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.
Harlan L; Brawley O; Pommerenke F; Wali P; Kramer B
J Clin Oncol; 1995 Jan; 13(1):93-100. PubMed ID: 7799048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]